Medscape

Oxygen for Moderate COPD?

Nevertheless, further studies were validated not only because there were indications that a subset of patients with moderately severe COPD might have benefitted by oxygen supplementation but also ...
Monthly Prescribing Reference

Mepolizumab Yields Lower Rate of Moderate/Severe Exacerbations in COPD

Compared with placebo, the time to first moderate or severe exacerbation was longer with mepolizumab. HealthDay News — For patients with chronic obstructive pulmonary disease (COPD) with a history of ...
Healio

Ensifentrine improves outcomes in both moderate, severe COPD

Please provide your email address to receive an email when new articles are posted on . Patients with moderate or severe COPD experienced improvements with 3 mg of twice-daily ensifentrine. Study ...
Healio

GOLD COPD exacerbation history groups ‘mediocre’ in exacerbation risk estimation

Please provide your email address to receive an email when new articles are posted on . Risk estimation was based on area under the receiver operating characteristic curve, sensitivity and specificity ...
Medscape

Efficacy of Pulmonary Rehabilitation in Patients With Moderate Chronic Obstructive Pulmonary Disease

Patients were recruited by their family physician from 7 primary care practices in Palma de Mallorca, Spain, from July 2005 to March 2007. Patients were identified from both the health center COPD ...
MedPage Today

Are Antibiotics Needed for Moderate Acute Exacerbations of COPD?

BARCELONA -- The need for antibiotics in patients with chronic obstructive pulmonary disease (COPD) seeking treatment for moderate acute COPD exacerbations could not be ruled out in a randomized trial ...
News Medical

Diabetes medications may help lower COPD flare-up risk, study finds

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...
MedPage Today

Home Oxygen Therapy May Not Benefit Patients With COPD and Moderate Hypoxemia

The clinical and survival benefit of home oxygen therapy, both LTOT and nocturnal oxygen therapy, for patients with COPD and moderate hypoxemia was evaluated in this meta-analysis. Home oxygen therapy ...
Nasdaq

Press Release: Itepekimab met the primary endpoint in one of two COPD phase 3 studies

AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically ...
Monthly Prescribing Reference

Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations

Researchers found that the risk for moderate or severe COPD exacerbation was lower among those treated with SGLT-2is vs DPP-4is and among those treated with GLP-1 RAs vs DPP-4is. HealthDay News — For ...
Nasdaq

Upstream Bio Initiates Phase 2 VENTURE Trial for Verekitug in Moderate-to-Severe COPD, Expanding Its Respiratory Portfolio

Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...
PharmaTimes

Tozorakimab shows significant benefit in two major COPD trials

Positive high‑level results from the phase 3 OBERON and TITANIA trials indicate that tozorakimab achieved statistically significant and clinically meaningful reductions in the a ...